Abattis Bioceuticals (ATTBF) 0.0980 $ATTBF
Abattis Selects Ingredient Identity as Global Regulatory Management Partner
Marketwired - Mon May 11, 7:36AM CDT
Abattis Bioceuticals Corp. (the "Company" or "Abattis"

(OTCQX: ATTBF)(CSE: ATT), a specialty biotechnology company with capabilities through its wholly-owned subsidiaries of cultivating, licensing and marketing proprietary ingredients, bio-similar compounds, patented equipment and consulting services to medicinal markets in North America, is pleased to announce the engagement of Ingredient Identity, a preeminent regulatory management consulting firm to the Food, Dietary Supplement, Cosmetic and Homeopathic industries globally.
Abattis Appoints Hugh Oswald as Investor Relations
Marketwired - Fri May 01, 10:10AM CDT
Abattis Bioceuticals Corp. (the "Company" or "Abattis"

(OTCQX: ATTBF) (CSE: ATT), specialty biotechnology company with capabilities through its wholly-owned subsidiaries as a botanical drug development company that develops and licenses natural health products, medicines, extractions and ingredients for the biologics, nutraceutical, bioceutical and cosmetic markets - some of which will contain cannabinoid compounds, today announced that Hugh Oswald, will assume the role of Investor Relations of Abattis Bioceuticals Corp. effective April 29, 2015.
Abattis Bioceuticals Investor Update for Q2 2015
Marketwired - Tue Apr 28, 7:31AM CDT
Abattis Bioceuticals Corp. (the "Company" or "Abattis"

(CSE: ATT)(OTCQX: ATTBF), a botanical drug development company that develops and licenses natural health products, medicines, extractions and ingredients for the pharmaceutical, nutraceutical, bioceutical and cosmetic markets - some of which will contain cannabinoid compounds, today announces a press release to update its current shareholders.
DigiPath Draws Press Coverage as Nevada Lab Prepares to Open
ACCESSWIRE - Mon Apr 27, 11:05AM CDT
WHITEFISH, MT / ACCESSWIRE / April 27, 2015 / Nevada legalized medical marijuana 15 years ago, but dispensaries are just now becoming a reality in the state. Given its large tourism industry and reciprocity laws, some analysts have projected that the state's cannabis industry could exceed $100 million in size over the coming years. The only thing holding the industry back are three bills that are currently pending in the state legislature which will finalize what the cannabis labs will be required to test for.
Abattis CEO Roadshow
Marketwired - Mon Apr 20, 1:20PM CDT
Abattis Bioceuticals Corp. (the "Company" or "Abattis"

(OTCQX: ATTBF)(CSE: ATT), a specialty biotechnology company with capabilities through its wholly-owned subsidiaries of cultivating, licensing and marketing proprietary ingredients, bio-similar compounds and patented equipment to medicinal markets in North America, would like to today announced that the Company's CEO, William Fleming ("Bill"

wants to thank those that he has had the opportunity to meet during the most recent Company roadshow.
Reviews Of 15 Marijuana Stocks Before The Marijuana Investor Summit - Part I
Anthony Cataldo - at Seeking Alpha - Wed Apr 15, 9:38AM CDT
Affinor Growers and Abattis Bioceuticals Corp. Amicably Resolve Washington Litigation and Agree to Dismiss the Case With Prejudice
Marketwired - Fri Apr 10, 12:07PM CDT
Abattis Bioceuticals Corp. (OTCQX: ATTBF)(CSE: ATT) ("Abattis"

wish to advise their shareholders that the litigation filed in King County, Washington State by Abattis and against Affinor, Affinor's Executive Director Nick Brusatore, and Affinor Growers LLC, has been amicably resolved and dismissed, leaving open the likelihood that the two companies will collaborate together in the future. Both parties unanimously agree that the lawsuits were both costly and time-consuming and a distraction for the growth of shareholder value for their respective companies.
Abattis Information to Be Available in S&P Capital IQ Market Access Program
Marketwired - Wed Mar 25, 3:01PM CDT
Abattis Bioceuticals Corp. (the "Company" or "Abattis"

(OTCQX: ATTBF)(CSE: ATT), a specialty biotechnology company with capabilities through its wholly-owned subsidiaries of cultivating, licensing and marketing proprietary ingredients, bio-similar compounds and patented equipment to medicinal markets in North America, would like to announced today that its company information will be made available via S&P Capital IQ's Market Access Program, an information distribution service that enables subscribing publicly traded companies to have their company information disseminated to users of S&P Capital IQ's MarketScope Advisor. The company information to be made available through this program includes share price, volume, dividends, shares outstanding, company financial position, and earnings. MarketScope Advisor is an Internet-based research engine used by more than 100,000 investment advisors. A public version of the site is available at
http://advisor.marketscope.com.
MHFI: 105.70 (-0.10)
S&P Capital IQ Initiates Coverage on Abattis Bioceuticals Corp. in S&P Capital IQ Factual Stock Reports
PR Newswire - Wed Mar 25, 1:44PM CDT
S&P Capital IQ (MHFI) announced today that it has commenced Factual Stock Report coverage on Abattis Bioceuticals Corp.
MHFI: 105.70 (-0.10)
Abattis Announces Private Placement
Marketwired - Mon Mar 09, 3:29PM CDT
Abattis Bioceuticals Corp. (the "Company" or "Abattis"

(OTCQX: ATTBF)(CSE: ATT), a specialty biotechnology company with capabilities through its wholly-owned subsidiaries of cultivating, licensing and marketing proprietary ingredients, bio-similar compounds, patented equipment and consulting services to medicinal markets in North America, would like to announce a proposed private placement of up to $250,000.
Baby Boomers Spend Billions to Stay Young
GlobeNewswire - Mon Mar 09, 8:30AM CDT
By Financial Press -- According to New York based Transparency Market Research the global nutraceuticals market will reach $204 billion by 2017 - fueled by health obsessed baby-boomers - who still ski and play competitive sports into their 60s and 70s.
Pot Stock Crash Redux: $23.3B Loss?
Matthew Finston - at Seeking Alpha - Sun Mar 08, 12:42AM CST
48 Marijuana Stocks - A Post-Mortem: Part I
Anthony Cataldo - at Seeking Alpha - Tue Mar 03, 1:27AM CST
GWPH: 112.25 (-0.07)